BlueCrest Capital Management’s Axcelis ACLS Stock Holding History

BlueCrest Capital Management’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,982	Closed	-$590K	–	1452
2018 Q1	$590K	Buy	+23,982	New	+$630K	0.02%	686

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BlueCrest Capital Management's ACLS Position: Q2 2018 in Review

BlueCrest Capital Management sold out of Axcelis (ACLS) in Q2 2018, closing a stake of 23,982 shares — an estimated $590K sold.

BlueCrest Capital Management first reported a position in ACLS in Q1 2018 and held it in 1 quarter. The position peaked at $590K in Q1 2018. 165 funds tracked by Wall St. Rank hold ACLS as of Q2 2018.

BlueCrest Capital Management reported no remaining Axcelis position as of Q2 2018 after selling out during the quarter.
BlueCrest Capital Management sold 23,982 Axcelis shares in Q2 2018, an estimated $590K.
BlueCrest Capital Management first reported a position in Axcelis in Q1 2018 and held it in 1 quarter.
BlueCrest Capital Management's Axcelis position peaked at $590K in Q1 2018.
165 funds tracked by Wall St. Rank held Axcelis as of Q2 2018.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.